A practical approach to T-cell receptor cloning and expression

PLoS ONE

Volumn 6, Issue 11, 2011, Pages

  Wälchli, Sébastien ^a   Løset, Geir Åge ^a,b   Kumari, Shraddha ^a   Johansen, Jorunn Nergård ^a   Yang, Weiwen ^a   Sandlie, Inger ^a,b   Olweus, Johanna ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; INTERLEUKIN 2; MELAN A; MESSENGER RNA; T LYMPHOCYTE RECEPTOR; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; LYMPHOCYTE ANTIGEN RECEPTOR;

5' RACE AMPLIFICATION; AMINO ACID SEQUENCE; ARTICLE; CD8+ T LYMPHOCYTE; CELL CLONE; CONTROLLED STUDY; DNA RECOMBINATION; ELECTROPORATION; GENE AMPLIFICATION; GENE EXPRESSION SYSTEM; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKEMIA CELL LINE; MOLECULAR CLONING; PROTEIN ANALYSIS; RELIABILITY; RNA DEGRADATION; T LYMPHOCYTE ACTIVATION; TRANSGENE; GENE VECTOR; GENETIC RECOMBINATION; GENETICS; METABOLISM; METHODOLOGY; REPRODUCIBILITY; RETROVIRUS;

CLONING, MOLECULAR; ELECTROPORATION; GENETIC VECTORS; HUMANS; JURKAT CELLS; MART-1 ANTIGEN; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; RECOMBINATION, GENETIC; REPRODUCIBILITY OF RESULTS; RETROVIRIDAE; RNA, MESSENGER;

EID: 84859222753     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0027930     Document Type: Article

References (44)

1. Kieback E, Uckert W, (2010) Enhanced T cell receptor gene therapy for cancer. Expert Opin Biol Ther 10: 749-762.
2. Ochi T, Fujiwara H, Yasukawa M, (2011) Requisite considerations for successful adoptive immunotherapy with engineered T-lymphocytes using tumor antigen-specific T-cell receptor gene transfer. Expert Opin Biol Ther 11: 699-713.
3. Schmitt TM, Ragnarsson GB, Greenberg PD, (2009) T cell receptor gene therapy for cancer. Hum Gene Ther 20: 1240-1248.
4. Schumacher TN, (2002) T-cell-receptor gene therapy. Nat Rev Immunol 2: 512-519.
5. Morgan RA, Dudley ME, Wunderlich JR, Hughes MS, Yang JC, et al. (2006) Cancer regression in patients after transfer of genetically engineered lymphocytes. Science 314: 126-129.
6. Hedrick SM, Cohen DI, Nielsen EA, Davis MM, (1984) Isolation of cDNA clones encoding T cell-specific membrane-associated proteins. Nature 308: 149-153.
7. Siu G, Clark SP, Yoshikai Y, Malissen M, Yanagi Y, et al. (1984) The human T cell antigen receptor is encoded by variable, diversity, and joining gene segments that rearrange to generate a complete V gene. Cell 37: 393-401.
8. Genevee C, Diu A, Nierat J, Caignard A, Dietrich PY, et al. (1992) An experimentally validated panel of subfamily-specific oligonucleotide primers (V alpha 1-w29/V beta 1-w24) for the study of human T cell receptor variable V gene segment usage by polymerase chain reaction. Eur J Immunol 22: 1261-1269.
9. Paliard X, West SG, Lafferty JA, Clements JR, Kappler JW, et al. (1991) Evidence for the effects of a superantigen in rheumatoid arthritis. Science 253: 325-329.
10. Moysey R, Vuidepot AL, Boulter JM, (2004) Amplification and one-step expression cloning of human T cell receptor genes. Anal Biochem 326: 284-286.
11. Dash P, McClaren JL, Oguin TH 3rd, Rothwell W, Todd B, et al. (2010) Paired analysis of TCRalpha and TCRbeta chains at the single-cell level in mice. J Clin Invest 121: 288-295.
12. Ozawa T, Tajiri K, Kishi H, Muraguchi A, (2008) Comprehensive analysis of the functional TCR repertoire at the single-cell level. Biochem Biophys Res Commun 367: 820-825.
13. Rosenberg WM, Moss PA, Bell JI, (1992) Variation in human T cell receptor V beta and J beta repertoire: analysis using anchor polymerase chain reaction. Eur J Immunol 22: 541-549.
14. Tsuruta Y, Iwagami S, Furue S, Teraoka H, Yoshida T, et al. (1993) Detection of human T cell receptor cDNAs (alpha, beta, gamma and delta) by ligation of a universal adaptor to variable region. J Immunol Methods 161: 7-21.
15. Ferradini L, Roman-Roman S, Azogui O, Genevee C, Viel S, et al. (1993) The use of anchored polymerase chain reaction for the study of large numbers of human T-cell receptor transcripts. Mol Immunol 30: 1143-1150.
16. Birkholz K, Hofmann C, Hoyer S, Schulz B, Harrer T, et al. (2009) A fast and robust method to clone and functionally validate T-cell receptors. J Immunol Methods 346: 45-54.
17. Zhao Y, Zheng Z, Robbins PF, Khong HT, Rosenberg SA, et al. (2005) Primary human lymphocytes transduced with NY-ESO-1 antigen-specific TCR genes recognize and kill diverse human tumor cell lines. J Immunol 174: 4415-4423.
18. Dembic Z, Haas W, Weiss S, McCubrey J, Kiefer H, et al. (1986) Transfer of specificity by murine alpha and beta T-cell receptor genes. Nature 320: 232-238.
19. Uckert W, Schumacher TN, (2009) TCR transgenes and transgene cassettes for TCR gene therapy: status in 2008. Cancer Immunol Immunother 58: 809-822.
20. Coccoris M, Straetemans T, Govers C, Lamers C, Sleijfer S, et al. (2010) T cell receptor (TCR) gene therapy to treat melanoma: lessons from clinical and preclinical studies. Expert Opin Biol Ther 10: 547-562.
21. Govers C, Sebestyen Z, Coccoris M, Willemsen RA, Debets R, (2010) T cell receptor gene therapy: strategies for optimizing transgenic TCR pairing. Trends Mol Med 16: 77-87.
22. Aarnoudse CA, Kruse M, Konopitzky R, Brouwenstijn N, Schrier PI, (2002) TCR reconstitution in Jurkat reporter cells facilitates the identification of novel tumor antigens by cDNA expression cloning. Int J Cancer 99: 7-13.
23. Szymczak AL, Workman CJ, Wang Y, Vignali KM, Dilioglou S, et al. (2004) Correction of multi-gene deficiency in vivo using a single 'self-cleaving' 2A peptide-based retroviral vector. Nat Biotechnol 22: 589-594.
24. Coulie PG, Brichard V, Van Pel A, Wolfel T, Schneider J, et al. (1994) A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J Exp Med 180: 35-42.
25. Stronen E, Abrahamsen IW, Gaudernack G, Walchli S, Munthe E, et al. (2009) Dendritic cells engineered to express defined allo-HLA peptide complexes induce antigen-specific cytotoxic T cells efficiently killing tumour cells. Scand J Immunol 69: 319-328.
26. Mills DR, Kramer FR, (1979) Structure-independent nucleotide sequence analysis. Proc Natl Acad Sci U S A 76: 2232-2235.
27. Giudicelli V, Duroux P, Ginestoux C, Folch G, Jabado-Michaloud J, et al. (2006) IMGT/LIGM-DB, the IMGT comprehensive database of immunoglobulin and T cell receptor nucleotide sequences. Nucleic Acids Res 34: D781-784.
28. Sensi M, Traversari C, Radrizzani M, Salvi S, Maccalli C, et al. (1995) Cytotoxic T-lymphocyte clones from different patients display limited T-cell-receptor variable-region gene usage in HLA-A2-restricted recognition of the melanoma antigen Melan-A/MART-1. Proc Natl Acad Sci U S A 92: 5674-5678.
29. Dietrich PY, Le Gal FA, Dutoit V, Pittet MJ, Trautman L, et al. (2003) Prevalent role of TCR alpha-chain in the selection of the preimmune repertoire specific for a human tumor-associated self-antigen. J Immunol 170: 5103-5109.
30. Trautmann L, Labarriere N, Jotereau F, Karanikas V, Gervois N, et al. (2002) Dominant TCR V alpha usage by virus and tumor-reactive T cells with wide affinity ranges for their specific antigens. Eur J Immunol 32: 3181-3190.
31. Baer R, Forster A, Rabbitts TH, (1987) The mechanism of chromosome 14 inversion in a human T cell lymphoma. Cell 50: 97-105.
32. Carrasco YR, Ramiro AR, Trigueros C, de Yebenes VG, Garcia-Peydro M, et al. (2001) An endoplasmic reticulum retention function for the cytoplasmic tail of the human pre-T cell receptor (TCR) alpha chain: potential role in the regulation of cell surface pre-TCR expression levels. J Exp Med 193: 1045-1058.
33. Padovan E, Casorati G, Dellabona P, Meyer S, Brockhaus M, et al. (1993) Expression of two T cell receptor alpha chains: dual receptor T cells. Science 262: 422-424.
34. Yang S, Cohen CJ, Peng PD, Zhao Y, Cassard L, et al. (2008) Development of optimal bicistronic lentiviral vectors facilitates high-level TCR gene expression and robust tumor cell recognition. Gene Ther 15: 1411-1423.
35. Leisegang M, Engels B, Meyerhuber P, Kieback E, Sommermeyer D, et al. (2008) Enhanced functionality of T cell receptor-redirected T cells is defined by the transgene cassette. J Mol Med 86: 573-583.
36. Osborn MJ, Panoskaltsis-Mortari A, McElmurry RT, Bell SK, Vignali DA, et al. (2005) A picornaviral 2A-like sequence-based tricistronic vector allowing for high-level therapeutic gene expression coupled to a dual-reporter system. Mol Ther 12: 569-574.
37. Boria I, Cotella D, Dianzani I, Santoro C, Sblattero D, (2008) Primer sets for cloning the human repertoire of T cell Receptor Variable regions. BMC Immunol 9: 50.
38. Saeboe-Larssen S, Fossberg E, Gaudernack G, (2002) mRNA-based electrotransfection of human dendritic cells and induction of cytotoxic T lymphocyte responses against the telomerase catalytic subunit (hTERT). J Immunol Methods 259: 191-203.
39. Engels B, Cam H, Schuler T, Indraccolo S, Gladow M, et al. (2003) Retroviral vectors for high-level transgene expression in T lymphocytes. Hum Gene Ther 14: 1155-1168.
40. Johnson LA, Heemskerk B, Powell DJ Jr, Cohen CJ, Morgan RA, et al. (2006) Gene transfer of tumor-reactive TCR confers both high avidity and tumor reactivity to nonreactive peripheral blood mononuclear cells and tumor-infiltrating lymphocytes. J Immunol 177: 6548-6559.
41. Lissina A, Ladell K, Skowera A, Clement M, Edwards E, et al. (2009) Protein kinase inhibitors substantially improve the physical detection of T-cells with peptide-MHC tetramers. J Immunol Methods 340: 11-24.
42. Rubio V, Stuge TB, Singh N, Betts MR, Weber JS, et al. (2003) Ex vivo identification, isolation and analysis of tumor-cytolytic T cells. Nat Med 9: 1377-1382.
43. Wilde S, Sommermeyer D, Frankenberger B, Schiemann M, Milosevic S, et al. (2009) Dendritic cells pulsed with RNA encoding allogeneic MHC and antigen induce T cells with superior antitumor activity and higher TCR functional avidity. Blood 114: 2131-2139.
44. Ahmadi M, King JW, Xue SA, Voisine C, Holler A, et al. (2011) CD3 limits the efficacy of TCR gene therapy in vivo. Blood 118: 3528-3537.